Russell Brown is a seasoned strategic leader whose career spans high‑level operations, organizational development, and national program expansion. With a proven track record of building scalable systems,strengthening institutional partnerships, and guiding organizations through periods of rapid growth, he brings a critical operational lens to emerging healthcare innovations.

In his role supporting Idrasil® and its parent company C3 International, Russell’s expertise directly advances the company’s mission to deliver the first standardized, pharmaceutical‑grade cannabinoid tablet to patients across the country and around the world. His background in complex program management and national‑level coordination positions him as a keydriver in expanding Idrasil’s footprint, strengthening regulatory alignment, and building the infrastructure required for sustainable global distribution.